https://shareandcaretowin.com/
Home :: Acurastem
https://www.prnewswire.com/news-releases/cirm-awards-acurastem-7-5-million-in-grant-funding-to-advance-as-241-toward-a-firstinhuman-trial-for-als-and-ftd-302756016.html
CIRM Awards AcuraStem $7.5 Million in Grant Funding to Advance AS-241 Toward a First-in-Human Trial...
/PRNewswire/ -- AcuraStem, a biotechnology company advancing treatments for amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), and other...
https://stemcell.keck.usc.edu/acurastem-awarded-dod-grant-for-als-drug-candidate/
AcuraStem awarded $1 million Department of Defense grant to develop ALS drug candidate - USC Stem...
Jun 1, 2024 - AcuraStem, a patient-based drug discovery platform company developing novel therapeutics for amyotrophic lateral sclerosis (ALS) and neurodegenerative...